Total Cholesterol Test Systems in Canada vs the US: Which Class Applies?

Graduated plastic specimen container with a screw cap on a dark background

Quick facts

  • A cholesterol (total) test system is a device intended to measure cholesterol in plasma and serum, used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and of lipid and lipoprotein metabolism disorders.
  • In the United States it is a named entry. 21 CFR 862.1175, Cholesterol (total) test system, is Class I (general controls), with product codes CHD, CHH, NFX, CGO and NAQ read from the openFDA classification database.
  • Canada keeps no named entry and classes the system as an in vitro diagnostic device under Part 2 of Schedule 1. This is the one topic in the batch where the two countries land in different classes: Class I in the United States, Class II in Canada.
  • Part 2 Rule 4 places an IVDD used in diagnosis that is not covered by Rules 1 to 3 in Class II, unless it falls into one of six listed categories, which then make it Class III.
  • For a near-patient version the answer is also Class II, and the route is a table entry rather than a rule reading: Part 2 Rule 9 lists a near patient in vitro diagnostic device for determining cholesterol level at Class II.
  • Entries, classes and product codes below were checked against the eCFR, the Regulations and the openFDA classification database on 2026-10-16.

A total cholesterol test system measures cholesterol in plasma and serum. It is a small assay on a routine panel, and it is the clearest example in this batch of a device that is Class I in the United States and Class II in Canada. The reason is not a disagreement about risk; it is that Canada classes every in vitro diagnostic device under a separate part of Schedule 1 that has its own default class. This article sets out both routes, the near-patient table entry that surprises most readers, and the record a bench keeps, with the 120 mL sterile screw-cap specimen container that carries the specimen.

What is a cholesterol (total) test system?

It is an assay system that measures total cholesterol in plasma or serum. The US identification text ties the measurement to a clinical purpose: cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders. The device is a test system, which means the reagents, the calibrators and the reading step are supplied together as one product rather than assembled by the user.

The distinction between a total cholesterol assay and a near-patient cholesterol device is worth holding on to, because Canada draws it. The same chemistry can be run on a laboratory bench and offered at a point of care, and the Canadian class comes out the same either way - but it comes out of two different places in Part 2, and one of them is a table row rather than a rule.

Graduated plastic specimen container with a screw cap on a dark background

What class is it in the United States?

It is a named entry at 21 CFR 862.1175, titled Cholesterol (total) test system. The identification reads: "A cholesterol (total) test system is a device intended to measure cholesterol in plasma and serum. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders." The regulation sets Class I (general controls).

The openFDA device classification API returns five product codes against the section, all Class I: CHD (acid, ferric ion-sulfuric), CHH (enzymatic esterase-oxidase), NFX (test, cholesterol, total, over the counter), CGO (Lieberman-Burchard or Abell-Kendall colorimetric) and NAQ (lipoprotein, high-density, over the counter). One regulation number therefore covers laboratory and over-the-counter chemists under the same class.

Item Detail
US regulation 21 CFR 862.1175 - Cholesterol (total) test system
US class Class I (general controls), all five product codes
Product codes CHD, CHH, NFX, CGO, NAQ
Stated intended use Measure cholesterol in plasma and serum, for diagnosis and treatment of cholesterol and lipid disorders
Premarket route Exempt from premarket notification, subject to the limitations of the exemption
Read on eCFR identification text and openFDA classification, both read 2026-10-16

How does Canada classify it?

There is no named entry, and an in vitro diagnostic device is classified under Part 2 of Schedule 1. A total cholesterol assay tests blood for an analyte rather than detecting a transmissible agent, so Part 2 Rules 1 and 2 do not apply and Rule 3, the patient-management rule, does not reach an assay used to diagnose and monitor rather than to manage a named patient group.

Part 2 Rule 4 is the rule that applies: "An IVDD that is not subject to rules 1 to 3 and that is intended to be used in diagnosis or patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III", after which the rule lists screening for or diagnosis of cancer, genetic testing, screening for congenital disorders in the fetus, a risk of death or severe disability from an erroneous diagnostic result, disease staging, and monitoring of drugs, substances or biological components where an erroneous result leads to an imminent life-threatening decision. A total cholesterol assay for routine use is at Class II.

A near-patient version reaches the same class by a different route. Part 2 Rule 9 says that despite Rules 1 to 8, an IVDD set out in the table to that rule is classified as the class set out for it, and item 2 of that table lists "Near patient in vitro diagnostic device for determining cholesterol level" at Class II. That table matters, because the general near-patient rule, Part 2 Rule 6, states that a near patient IVDD is classified as Class III - so a reader who stops at Rule 6 would over-class a cholesterol device by one class.

Foldable examination table covered with a light blue disposable protective sheet

Why is a cholesterol test Class I in one country and Class II in the other?

Because Canada gives every in vitro diagnostic device a floor of Class II. The US route names the device and attaches the class written in the entry, and 862.1175 was written as a Class I entry that is exempt from premarket notification. Canada keeps no entry and applies Part 2, where the diagnostic use itself places the device in Class II.

This is a real class difference and it is not a disagreement about the chemistry. The same assay, the same sample volume and the same reporting unit sit in different classes because the two jurisdictions ask different first questions. For a Canadian laboratory the practical effect is that a device which arrives with no US premarket submission cannot be assumed to be an unlicensed device at home: a device licence is the Canadian instrument, and the class it carries is set by Part 2.

Item Canada United States
Named entry None; classified under Part 2 of Schedule 1 862.1175 - Cholesterol (total) test system
Class, laboratory assay Class II (Part 2 Rule 4) Class I
Class, over-the-counter chemist Class II where the near-patient table entry applies Class I
Near-patient rule Rule 6 sets Class III generally; Rule 9 item 2 sets cholesterol at Class II Not addressed in the entry
Governing text Schedule 1, Part 2, Rules 4, 6 and 9 21 CFR 862.1175
Premarket route Device licence at the applicable class Exempt from premarket notification, subject to the exemption limits

What should a laboratory check before ordering?

Four checks. First, confirm whether the system is a laboratory assay or a near-patient device, because the route to Class II differs and the labelling obligations differ with it. Second, confirm the intended-use wording, since a claim that reaches disease staging or drug monitoring can lift the class to Class III.

Third, confirm the specimen container and the minimum volume the system accepts, because a cholesterol result shifts with the specimen handling rather than with the photometer. Fourth, confirm the calibration interval and the control material that the maker states, so that a result can be compared with the one taken at the previous visit.

Containers and tubes are reordered on their own cycle, separate from the assay. Laboratories buying for several sites order through the wholesale programme. Clinics that stock for a whole practice can order through the wholesale programme for case pricing and account setup; resellers can become a distributor. The 120 mL sterile screw-cap specimen container sits in the same catalogue. Consumables for this line are listed under diagnostic laboratories.

How does the class affect what a bench records?

The class sets the licence path and the conditions attached to it. It does not set the bench routine. What is recorded is set by the maker's instructions and the laboratory's own quality system: the specimen identifier, the collection time, the assay lot, the calibrator, the control result, the instrument and the operator.

The same shape of record is kept whether the assay is run on a laboratory analyser or at a point of care, because a cholesterol value is only useful when it can be compared with the previous one, and a comparison needs the instrument, the calibration and the control named. The class answers who reviews the device before it is sold; the record answers whether the number can be trusted.

Sources

  1. openFDA device classification API
  2. Medical Devices Regulations, SOR/98-282, full text and Schedule 1
  3. US FDA, medical device databases
  4. US FDA, overview of device regulation
  5. Health Canada, medical devices
  6. Health Canada, establishment licensing
  7. ISO 15189:2022, medical laboratories, requirements for quality and competence
  8. ISO 17511:2020, metrological traceability of values assigned to calibrators
  9. ISO 13485:2016, medical devices quality management
  10. ISO 14971:2019, application of risk management to medical devices
  11. ISO 11137-1:2006, radiation sterilization of health care products
  12. ISO 20776-1:2019, susceptibility testing of infectious agents
  13. Clinical and Laboratory Standards Institute
  14. World Health Organization
  15. US CDC, laboratory quality
  16. Public Health Ontario, infection prevention and control
  17. Standards Council of Canada

Printable record sheet. A lipid-panel record sheet holds the specimen identifier, the assay lot, the control result and the operator on one printable page. Print the lipid-panel record sheet — from the compliance log centre - no account and no sign-up.

Log generator. Enter the laboratory, the analyser and the panel once and the sterilization log generator — returns a dated, facility-labelled sheet you can file with the run records.

Ask a compliance specialist. A classification question usually turns on how the device is used, not only on its name. Ask a compliance specialist — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.

Related reading

CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.

Frequently Asked Questions

What class is a total cholesterol test system in the United States?

Class I, under the named entry at 21 CFR 862.1175, with product codes CHD, CHH, NFX, CGO and NAQ. The entry covers laboratory and over-the-counter chemists alike.

What class is it in Canada?

Class II. A total cholesterol assay is an IVDD classified under Part 2 Rule 4 of Schedule 1, which places a diagnostic IVDD at Class II unless one of the listed lifts applies.

Why are the two classes different?

Canada gives in vitro diagnostic devices a Part 2 classification with a Class II default for diagnostic use, while the US entry for this assay was written as Class I and is exempt from premarket notification.

Is a near-patient cholesterol device Class III in Canada?

No. Part 2 Rule 6 classes a near patient IVDD as Class III in general, but Part 2 Rule 9 overrides Rules 1 to 8 for the items in its table, and item 2 sets a near patient device for determining cholesterol level at Class II.

Could the class ever be Class III?

Yes, where the intended use falls into one of the Rule 4 categories - for example disease staging, or monitoring a substance where an erroneous result leads to an imminent life-threatening decision.

Does the class change how a cholesterol result is recorded?

No. The class sets the licence path. The record - specimen, assay lot, calibrator, control and operator - is set by the maker's instructions and the laboratory quality system.

Vous travaillez déjà avec des cliniques ? Devenez représentant régional.